Log in or Sign up for Free to view tailored content for your specialty!
Gastrointestinal Cancer News
Virtual reality therapy offers ‘sustained improvement’ in cancer-related pain
Individuals with cancer reported significantly reduced pain immediately following a 10-minute virtual reality (VR) session, study results published in Cancer showed.
FDA grants accelerated approval to Enhertu for adults with advanced solid tumors
The FDA granted accelerated approval to fam-trastuzumab deruxtecan-nxki for the treatment of adults with unresectable or metastatic HER2-positive solid tumors who received previous systemic therapy and lack additional treatment options.
Log in or Sign up for Free to view tailored content for your specialty!
Most molecular-targeted cancer therapies show no ‘substantial’ benefit at approval
Fewer than one-third of recently approved molecular-targeted cancer therapies demonstrated “substantial patient benefits,” according to data published in JAMA Oncology.
New cancer diagnoses projected to reach 35 million worldwide in 2050
New global cancer diagnoses could reach 35 million by the year 2050, according to a report from the American Cancer Society published in CA: A Cancer Journal for Clinicians.
Global GI Oncology with Aparna Parikh, MD
In this episode, host Shikha Jain, MD, speaks with Aparna Parikh, MD, about cancer and GI malignancies in the global health space, circulating tumor DNA in the field of oncology and more.
Follow-up measure after stool-based CRC test feasible, could ensure ‘complete’ screening
A quality performance measure that tracks follow-up colonoscopy rates within 6 months of an abnormal stool-based screening test was feasible and had a median reliability of 94.5% across health care organizations, according to researchers.
Prediction model could prioritize high-risk patients awaiting surveillance colonoscopy
A multivariable risk prediction model “may be useful” for prioritizing patients at highest risk for colorectal cancer and awaiting surveillance colonoscopy when demand for the procedure is high, according to research in Gastro Hep Advances.
Coffee consumption may reduce colorectal cancer recurrence, all-cause mortality
Coffee consumption may reduce risk for colorectal cancer recurrence and all-cause mortality, according to research published in the International Journal of Cancer.
Rising incidence of advanced stage CRC in younger adults supports screening at age 45
Incidence rates of distant and regional stage colorectal adenocarcinoma have increased over the past two decades among those aged 46 to 49 years and should be considered when counseling patients on screening initiation, research showed.
‘Additional preventive’ benefit of colonoscopy for CRC falls short of sigmoidoscopy
Colonoscopy screening reduced the incidence of colorectal cancer and related mortality by 30% and 32%, respectively, compared with usual care, although the benefit was less than that of sigmoidoscopy where no screening exists, data showed.
-
Headline News
FDA warns of potential liver injury with Veozah for menopausal hot flashes
September 12, 20242 min read -
Headline News
Video games improved mental health during COVID-19 pandemic
September 12, 20242 min read -
Headline NewsSeptember 12, 20240 min read
-
Headline News
FDA warns of potential liver injury with Veozah for menopausal hot flashes
September 12, 20242 min read -
Headline News
Video games improved mental health during COVID-19 pandemic
September 12, 20242 min read -
Headline NewsSeptember 12, 20240 min read